Mama's Creations, Inc. (MAMA) Stock Price & Analysis
Mama's Creations, Inc. (MAMA) is trading at USD 11.88, up 1.97% today, as of November 18, 2026 at 20:52 UTC (US market open; quotes may be delayed), according to Nexqual market data.
MAMA last closed at USD 11.65; today's session has ranged USD 11.49–11.97 on volume of 841,426 shares. Market capitalization is $560.11M, with a 52-week range of USD 9.98–21 (NCM). Source: Nexqual, retrieved November 18, 2026 at 20:53 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MAMA.md
Key facts (MAMA)
- Last four reported quarters (through Jul 31, 2026): revenue $209M, net income $7.4M (3.5% margin), free cash flow $17.3M (SEC filings).
- Valuation: P/E 75.8x (avg 75.1x at the last 3 fiscal year-ends).
- 2 of 80 tracked superinvestors hold MAMA (13F, Q3 2026): 0 new, 1 added, 1 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $936K; 1 not under a Rule 10b5-1 plan ($9K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.89 on a 1–5 scale) (9 analysts), mean target USD 21.88 (range 19–25).
- Total return with dividends: 1Y +18.1% vs S&P 500 +11.9%; 5Y +437.6% vs S&P 500 +66.7%.
- Next earnings: 2026-12-03 (date not yet confirmed by the company), EPS estimate USD 0.07, revenue estimate $55.9M. All companies reporting that day: https://nexqual.com/earnings/2026-12-03
- Dividend: MAMA paid no cash dividend in the last five years.
- Short interest: 10.50% of float (as of 2026-10-30), 7.3 days to cover.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MAMA)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $48.8M | $95.4M | $103M | $123M | $172M | $209M |
| Gross profit | $11.9M | $19.4M | $30.3M | $30.5M | $43.0M | — |
| Operating income | $83K | $2.8M | $8.9M | $4.9M | $7.1M | $9.5M |
| Net income | -$252K | $2.3M | $6.6M | $3.7M | $5.3M | $7.4M |
| EPS (diluted) | -$0.01 | $0.06 | $0.17 | $0.09 | $0.13 | — |
| Free cash flow | -$9.5M | $4.9M | $10.8M | $82K | $9.8M | $17.3M |
| Gross margin | 24.3% | 20.4% | 29.4% | 24.8% | 25.1% | — |
| Operating margin | 0.2% | 3.0% | 8.6% | 4.0% | 4.1% | 4.5% |
| Net margin | -0.5% | 2.4% | 6.4% | 3.0% | 3.1% | 3.5% |
| Revenue growth | +19.7% | +95.5% | +8.2% | +19.4% | +39.2% | — |
| Cash + short-term investments | $851K | $4.4M | $11.0M | $7.2M | $20.0M | — |
| Total debt | — | $1.5M | $2.3M | $0K | $5.6M | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jul 31, 2026) (MAMA)
P/E 75.8x · P/S 2.7x · P/FCF 32.4x · P/B 3.4x · FCF yield 3.09% · Earnings yield 1.32%
P/E at fiscal year-ends: Jan 2026 118.2x, Jan 2025 81.8x, Jan 2024 25.2x.
Superinvestors (SEC 13F-HR, Q3 2026) (MAMA)
2 of 80 tracked investors hold MAMA. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.03% | $18.3M | Added +3.0% |
| Polen Capital | Polen Capital Management | 0.01% | $1.3M | Reduced -1.2% |
Insider sales (SEC Form 4, open-market, last ~7 months) (MAMA)
1 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Michaels Adam Laurance | Chief Executive Officer | 69,683 | $927K | 8.8% | Yes (adopted July 13, 2025) | Too little history (no open-market trades in 2023) |
| 2026-07-08 | Tappan Moore Iii | Chief Operating Officer | 472 | $9K | 3.5% | No | Too little history (no open-market trades in 2023 or 2024) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (MAMA)
Consensus Buy (mean 1.89 on a 1–5 scale), 9 analysts; mean target USD 21.88 (low 19, high 25).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-27 | Stephens & Co. | Initiated | Overweight | $19 |
| 2026-09-04 | DA Davidson | Target lowered | Buy | $25 → $22 |
| 2026-07-25 | William Blair | Initiated | Outperform | |
| 2026-07-22 | Benchmark | Initiated | Buy | $25 |
Total return (dividends reinvested) (MAMA)
| 1Y (from 2025-11-18) | 5Y (from 2021-11-15) | |
|---|---|---|
| Total return | +18.1% | +437.6% |
| S&P 500 (SPY) | +11.9% | +66.7% |
| Per year | +18.1% | +39.9% |
| Volatility (annualized) | 56.6% | 54.0% |
| Max drawdown | -43.6% (Jun 2026→Nov 2026) | -54.3% (Nov 2021→Nov 2022) |
Dividends (MAMA)
MAMA paid no cash dividend in the last five years.
Short interest (MAMA)
4,906,580 shares sold short, 10.50% of the float, as of Oct 30, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 30, 2026): 4,430,509 shares (+10.7%). Days to cover: 7.3 (short shares ÷ average daily volume).
MAMA earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Sep 3, 2026 | Quarter ended Jul 31, 2026 | $0.06 | $0.05 | Beat +20.0% | -3.0% |
| Jun 8, 2026 | Quarter ended Apr 30, 2026 | $0.05 | $0.03 | Beat +$0.02 | -10.8% |
| Apr 14, 2026 | Quarter ended Jan 31, 2026 | — | — | — | -1.1% |
| Dec 8, 2025 | Quarter ended Oct 31, 2025 | $0.03 | −$0.01 | Beat +$0.04 | +24.8% |
| Sep 8, 2025 | — | — | — | — | +0.1% |
| Sep 2, 2025 | — | — | — | — | +17.0% |
| Jun 3, 2025 | — | — | — | — | -1.6% |
| Apr 8, 2025 | — | — | — | — | -2.3% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
MAMA recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Nov 6, 2026 | Schedule 13G/A | FMR LLC, Abigail P. Johnson: 13.5% of shares, passive 5%+ holder (amended) |
| Nov 5, 2026 | Schedule 13G | FMR LLC, Abigail P. Johnson: 9.0% of shares, passive 5%+ holder |
| Oct 30, 2026 | Schedule 13G/A | Vanguard Capital Management: 4.7% of shares, passive 5%+ holder (amended) |
| Sep 3, 2026 | 8-K | Quarterly results |
| Sep 3, 2026 | 10-Q | Quarterly report · period ended Jul 31, 2026 |
| Jul 31, 2026 | Schedule 13G | Vanguard Capital Management: 5.0% of shares, passive 5%+ holder |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
MAMA suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Olive Branch | “Our Olive Branch brand concentrates on selling olives, olive mixes, and savory products to large retail customers, primarily in pre-packaged containers.” |
Quoted from the company's 10-K filed Apr 14, 2026.
MAMA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Oct 2026) | $0.07 | $0.06 | +8.3% | $55.9M | 2 |
| Next quarter (ends Jan 2027) | $0.08 | $0.08 | +0.0% | $60.9M | 2 |
| Current fiscal year (ends Jan 2027) | $0.24 | $0.24 | +0.0% | $224.1M | 2 |
| Next fiscal year (ends Jan 2028) | $0.35 | $0.35 | +0.0% | $251.9M | 2 |
MAMA options: expected move
Options price a move of about ±20.4% (±$2.38) by Dec 18, 2026, which includes earnings on Dec 3, 2026. Over the last 8 reports the stock moved ±7.6% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 2 | 71.0% | ±8.3% |
| Dec 18, 2026 | 30 | 62.3% | ±20.4% |
| Jan 15, 2027 | 58 | 60.5% | ±20.8% |
| Mar 19, 2027 | 121 | 53.4% | ±26.0% |
| Apr 16, 2027 | 149 | 62.4% | ±33.5% |
| May 21, 2027 | 184 | 60.3% | ±35.8% |
| Jun 17, 2027 | 211 | 58.6% | ±37.1% |
| Jul 16, 2027 | 240 | 65.3% | ±43.8% |
30-day implied volatility 57.3% vs 47.4% realized over the last 30 trading days. Put/call ratio (volume) 0.36. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of November 18, 2026 at 20:53 UTC)
| Price | USD 11.88 |
|---|---|
| Change | ▲ 1.97% (up) |
| Previous Close | USD 11.65 |
| Open | USD 11.65 |
| Day Range | USD 11.49 – 11.97 |
| 52-Week Range | USD 9.98 – 21 |
| Volume | 841,426 shares |
| Market Cap | $560.11M |
| Exchange | NCM |
Technical Analysis (MAMA)
Nexqual's technical model rates MAMA "STRONG SELL" based on 0 bullish and 5 bearish signals across 129 daily candles, as of November 18, 2026 at 20:53 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.32 (neutral) |
| vs SMA50 | Below (USD 13.17) |
| MACD | -0.28 (negative) |
Analyst Ratings (MAMA)
Wall Street analysts rate MAMA "Buy" based on 9 analysts, with a mean price target of USD 21.88 (range USD 19–25), per Nexqual as of November 18, 2026 at 20:53 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 21.88 |
| High Target | USD 25 |
| Low Target | USD 19 |
| Buy / Hold / Sell | 9 / 0 / 0 |
Earnings (MAMA)
| Next Earnings Date | 2026-12-03 |
|---|---|
| EPS Estimate | USD 0.07 |
| Revenue Estimate | $55.89M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-07-31 | USD 0.06 vs est 0.05 ▲ beat |
| 2026-04-30 | USD 0.05 vs est 0.03 ▲ beat |
| 2025-10-31 | USD 0.03 vs est -0.01 ▲ beat |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
Financials & Fundamentals (MAMA)
| Total Revenue | $208.60M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +55.00% |
| Gross Margin | +24.25% |
| Operating Margin | +5.17% |
| Profit Margin | +3.55% |
| ROE | +7.51% |
| Debt / Equity | 0.08 |
| Current Ratio | 6.93 |
| Total Cash | $138.62M |
| Total Debt | $12.92M |
| Free Cash Flow (last four quarters to Jul 2026, SEC 10-Q / 10-K) | $17.29M (8.3% of revenue) |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
Financial Health Score (MAMA)
Nexqual rates Mama's Creations, Inc.'s overall financial health "Solid" across five dimensions, as of November 18, 2026 at 20:53 UTC.
| Growth | Strong — Revenue +54% (last 4 quarters to Jul 2026 vs the 4 before, SEC) |
|---|---|
| Profitability | Weak — Gross margin 24%, operating 5% (last 4 quarters to Jul 2026, SEC) |
| Balance Sheet | Strong — $20M cash and investments vs $6M debt (Jan 2026, SEC), net cash |
| Cash Flow | Solid — FCF $17M (last 4 quarters to Jul 2026, SEC), 8% margin |
| Efficiency | Weak — ROE 4%, ROA 3.7% (last 4 quarters, SEC) |
Ownership (MAMA)
| Insider Ownership | +1.67% |
|---|---|
| Institutional Ownership | +91.56% |
| Shares Outstanding | 47.15M |
| Float | 43.11M |
| Short % of Float | +10.50% |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
Leadership (MAMA)
Mama's Creations, Inc. is led by Adam L. Michaels, CEO & Chairman, per Nexqual as of November 18, 2026 at 20:53 UTC.
| CEO & Chairman | Adam L. Michaels |
|---|---|
| Chief Financial Officer | Anthony J. Gruber |
| Chief Operating Officer | Moore Tappan |
| Managing Director of Investor Relations | Luke Zimmerman |
| Senior Vice President of Sales | Scott Shaffer |
Major Backers & Investors (MAMA)
Notable institutional backers of Mama's Creations, Inc. include FMR, LLC, Fidelity, Next Century Growth Investors LLC, according to Nexqual as of November 18, 2026 at 20:53 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 13.2% |
| Fidelity | 6.81% |
| Next Century Growth Investors LLC | 5.41% |
| Wasatch Advisors LP | 4.4% |
| Driehaus Capital Management, LLC | 4.06% |
| First Eagle Investment Management, LLC | 3.98% |
| Janus Henderson Group Ltd. | 3.77% |
| CALAMOS INVESTMENT TRUST/IL-Calamos Timpani Small Cap Growth Fund | 3.66% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.11% |
| Vanguard Group | 5.39% |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
From Mama's Creations, Inc.'s Latest SEC 10-K Filing (filed 2026-04-14)
Key Strengths & Strategy (as disclosed to the SEC)
- We are subject to the Food, Drug and Cosmetic Act and regulations promulgated thereunder by the FDA as well as related legislation, including the Food Safety Modernization Act.
- We rely on a combination of trademark, copyright and trade secret laws to establish and protect our proprietary rights.
- We will also use technical measures to protect our proprietary rights.
Legal & Regulatory Risks (Item 1A, quoted)
- The impact of various food safety issues, environmental, legal, tax, and other regulations and related developments could adversely affect our sales and profitability.
- Product liability or legal claims could result in significant costs and damage to our reputation.
- Failure to maintain effective internal controls could result in inaccurate reporting, regulatory penalties, and loss of investor confidence.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INGR | Ingredion Incorporated | USD 90.27 | ▼ 0.93% |
| PPC | Pilgrim's Pride Corporation | USD 27.88 | ▼ 2.11% |
| CAG | ConAgra Brands, Inc. | USD 14.87 | ▲ 1.33% |
| LW | Lamb Weston Holdings, Inc. | USD 52.01 | ▼ 3.99% |
| CPB | The Campbell's Company | USD 24.3 | ▲ 3.05% |
| SFD | Smithfield Foods, Inc. | USD 19.17 | ▲ 1.13% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt